Substance / Medication

Ceftibuten

Overview

Active Ingredient
ceftibuten
RxNorm CUI
20492

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

13 trials linked to this intervention

13
Total Trials
4
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
Cohen Stuart James, Leverstein-Van Hall Maurine, Kortmann Willemijn et al. · Eur J Clin Microbiol Infect Dis · 2018
PMID: 30117050Observational
Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children.
Mårild Staffan, Jodal Ulf, Sandberg Torsten · Pediatr Nephrol · 2009
PMID: 18818954Observational
Inhibitory effect of zinc on the absorption of beta-lactam antibiotic ceftibuten via the peptide transporters in rats.
Okamura Miyako, Terada Tomohiro, Katsura Toshiya et al. · Drug Metab Pharmacokinet · 2008
PMID: 19122341Observational
Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers.
Menon R M, Barr W H · Biopharm Drug Dispos · 2003
PMID: 14520683Observational
[Our experience with cedax (ceftibuten) in the obstetrical and gynecological practice].
Lazarov L, Lazarov N, Lazarova G · Akush Ginekol (Sofiia) · 2003
PMID: 12858490Observational
Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method.
Kleinkauf N, Rodloff A C · Clin Microbiol Infect · 2001
PMID: 11442566Observational
[Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis].
Otvagin I V, Kamanin E I, Strachunskiĭ L S et al. · Vestn Otorinolaringol · 2001
PMID: 11699089Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ceftibuten (substance)
SNOMED CT
387535008
UMLS CUI
C0055014
RxNorm CUI
20492

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

8
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
13
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.